COVID-19: How HRPPs are Preparing and Responding—A Discussion Forum


This webinar is free to all. Click here to access the webinar recording.

The COVID-19 pandemic is impacting human subjects research in unprecedented ways. This forum will provide an opportunity to hear from HRPP leaders representing universities, academic health care systems, and an independent IRB on the key issues and strategies HRPPs should be considering and implementing in the face of the COVID-19 pandemic. A significant portion of the forum will be devoted to open discussion of audience questions and concerns such as:

  • Shutdowns impacting therapeutic and non-therapeutic research—what to keep open, what to halt and what to close
  • Handling regulatory and reporting responsibilities and where to be flexible
  • Managing IRB review priorities
  • Dealing with staffing shortages and working remotely
  • Reviewing research related directly to COVID-19


Bruce G. Gordon, MD
Assistant Vice-Chancellor for Regulatory Affairs; Executive Chairman, IRBs; Professor, Pediatrics
University of Nebraska Medical Center

Martha F. Jones, MA, CIP
Vice President, Human Research Affairs
Partners HealthCare, Boston MA 

Megan Kasimatis Singleton, JD, MBE, CIP
Assistant Dean, Human Research Protection; Director, HRPP
Johns Hopkins University School of Medicine

Michele Russell-Einhorn, JD
Chief Compliance Officer and Institutional Official